American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
Lead: Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
Lead: Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
Tuesday 14th March 2023
Discover how COVID-19 regulatory changes enhanced methadone treatment and dive into other crucial addiction topics in this episode.
7 minutes
Informative
Empowering
Hopeful
Educational
Supportive
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
144 (View all)
Do you want to link to this podcast?
Get the buttons here!How COVID-19 Changed Methadone Treatment: What We Learned and What’s Next
Greater pandemic flexibility in methadone treatment for opioid use disorder poses no risk of increased methadone overdose and potentially improves treatment retention and patient quality of life.
Imagine navigating opioid use disorder treatment during a global pandemic. This episode of 'Addiction Medicine Unpacked' dives into a review article from The Lancet Public Health that examines how COVID-19 regulatory changes impacted methadone treatment. With more flexible take-home dosing policies, the study found no increase in methadone overdose risks. Instead, these changes led to better treatment retention and significantly improved patient quality of life. This has big implications as SAMHSA considers making these flexibilities permanent.
But that's not all you'll get in this episode. The podcast also touches on how cannabis legalization affects cannabis use disorder rates and discusses the benefits of extending buprenorphine treatment duration to reduce opioid overdose deaths. Curious about alcohol use and its link to depression? Or the impact of the Chantix recall on nicotine dependence medications? This episode covers those topics too, along with a thought-provoking opinion piece advocating for more client-centered care in opioid treatment programs.
Whether you're a healthcare professional or someone personally affected by addiction, this episode offers valuable insights into the evolving landscape of addiction medicine.